Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Brief Counseling for Weight Management
This study has been completed.
Study NCT00212199   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: September 13, 2005   Last Updated: December 14, 2007   History of Changes

September 13, 2005
December 14, 2007
January 2002
 
  • 1. Changes in body weight at 6, 12 and 24 months.
  • 2. Changes in body mass index (BMI) at 6, 12 and 24 months.
Same as current
Complete list of historical versions of study NCT00212199 on ClinicalTrials.gov Archive Site
  • 1. Changes in blood pressure at 6, 12 and 24 months.
  • 2. Changes in lipids at 6, 12 and 24 months.
  • 3. Changes in serum glucose at 6, 12 and 24 months.
Same as current
 
Effectiveness of Brief Counseling for Weight Management
Effectiveness of Brief Counseling for Weight Management

The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.

There is a growing demand for effective obesity treatments that don't require much time to implement especially in a primary health-care setting where time is especially limited. Brief interventions that might provide benefits similar to those produced by more time-intensive and costly lifestyle interventions would be very useful. There is also increasing interest in the efficacy of primary drug therapies for obesity. The purpose of this 12-month study, and 24-month follow-up, is to examine the efficacy of a brief behavioral counseling intervention alone or in combination with a drug already approved for the long-term management of obesity (orlisat)and compare both interventions to a drug alone condition.

Phase IV
Interventional
Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
1. Obesity
  • Drug: orlistat
  • Behavioral: Brief cognitive behavioral counseling
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
246
August 2004
 

Inclusion Criteria:

  • Body Mass Index of 30 to 40
  • Male or females ages of 25 to 55 years
  • Normal blood pressure or controlled with medicine
  • Females not lactating, able to get pregnant or using acceptable birth control
  • Current allowed medications prescribed at least 2 months prior to study

Exclusion Criteria:

  • Pregnant, planning to get pregnant or becomes pregnant
  • Insulin dependent diabetes
  • Uncontrolled hypertension
  • Prescence or history of significant medical conditions that could impact the outcome of the study
  • Prescence of active gastrointestinal disorders
  • History of mental disorders including eating disorders
  • Weight loss greater than 10 pounds in the last 3 months
  • History of alcohol or drug dependency
  • Use of any weight-loss medication in the last 6 months
  • Known allery to orlistat or any of its components
Both
25 Years to 55 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00212199
 
DK58299
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hoffmann-La Roche
Principal Investigator: John P Foreyt, PhD Baylor College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP